Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy

BACKGROUND: The efficacy of radiofrequency ablation (RFA) for patients with early-stage recurrent hepatocellular carcinoma (HCC) with microvascular invasion (MVI) at the initial hepatectomy is limited. Our study aimed to explore whether adjuvant sorafenib following RFA could improve the situation. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Meng-Chao, Zhang, Yao-Jun, Chen, Min-Shan, Chen, Yong, Lau, Wan-Yee, Peng, Zhen-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260661/
https://www.ncbi.nlm.nih.gov/pubmed/35814378
http://dx.doi.org/10.3389/fonc.2022.868429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260661/
https://www.ncbi.nlm.nih.gov/pubmed/35814378
http://dx.doi.org/10.3389/fonc.2022.868429

Ejemplares similares